(19)
(11) EP 4 739 799 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 23741992.4

(22) Date of filing: 07.07.2023
(51) International Patent Classification (IPC): 
C12Q 1/6883(2018.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/6883; C12Q 2600/112; C12Q 2600/118; C12Q 2600/158; C12Q 2600/178
(86) International application number:
PCT/EP2023/068898
(87) International publication number:
WO 2025/011736 (16.01.2025 Gazette 2025/03)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(71) Applicant: Genxpro GmbH
60438 Frankfurt am Main (DE)

(72) Inventors:
  • MAMEDE FIGUEIREDO, Ricardo
    3400-100 Oliveira do Hospital (PT)
  • HOFFMEIER, Klaus
    60439 Frankfurt am Main (DE)
  • ROTTER, Björn
    60320 Frankfurt am Main (DE)

(74) Representative: Kilian Kilian & Partner mbB 
Zielstattstraße 23a
81379 München
81379 München (DE)

   


(54) A METHOD FOR AN IN VITRO DIAGNOSIS, PROGNOSIS, STAGING AND/OR TREATMENT MONITORING OF A NEURODEGENERATIVE DISEASE, NEUROLOGICAL DISEASE OR AMYLOID BETA-RELATED DISEASE